Pharmascience Inc. v. Janssen Inc. — SCC Rules Pharmaceutical Dosing Regimens CAN Be Patented If They Don’t Require Medical Judgment (2026 SCC 26)
The Supreme Court of Canada rules 7-2 that methods of medical treatment remain unpatentable in Canada, but upholds Janssen’s dosing-regimen patent for INVEGA SUSTENNA because the specific schedule does not require professional medical judgment to implement.